2026年开年，跨境资本市场迎来双重变局。一方面，中国证监会赴美上市备案通道再度收紧；另一方面，纳斯达克新规于1月 17日正式生效，财务门槛一夜之间暴涨200% 。对于摩拳擦掌准备登陆美股的中小企业而言，前方的路似乎被骤然收紧的闸口 卡住了咽喉。 当理想遭遇现实，当纳斯达克的门槛变得高不可攀，一个务实的选项正在重回视野：美国OTC市场。虽然它从来不是企业 的"初恋"选择，但在当下的市场格局中，却成了中小企业活下去、等风来的无奈但现实的选择。 纳斯达克：从"梦想板"到"天花板" 曾几何时，纳斯达克是中国成长型企业最适配的资本市场，其对科技赛道的包容、对全球资本的集聚效应无可替代。但2026年 的新规彻底改写了游戏规则。 根据新规，以"净收入标准"上市的公司，最低要求从500万美元跃升至1500万美元，增幅达200% ；以"收入标准"上市的也从 800万美元提升至1500万美元，增幅87.5% 。更致命的是，纳斯达克被赋予了"实质裁量权" ——即使企业满足所有书面条件， 若交易所认为存在证券操纵的潜在风险，仍可直接拒绝上市申请 。这意味着，过去"技术性合规即可通关"的时代彻底终结。 对于大量营收刚破亿、利润刚转正 ...

Group 1: Current State of the US IPO Market - The US mainboard IPO market has seen increasing barriers for Chinese companies, with a decline in acceptance and rising costs, resulting in a "growing number, shrinking scale, and high thresholds" phenomenon [2] - In 2025, 63 Chinese companies are expected to go public in the US, raising only $1.12 billion, a significant 41% decrease from 2024, with an average fundraising amount of less than $20 million, far below historical levels [2] - New Nasdaq regulations set to take effect in 2026 will further exacerbate these challenges, raising the IPO net income standard from $5 million to $15 million (200% increase) and the revenue listing standard from $8 million to $15 million (87.5% increase) [2] Group 2: SEC Structural Reform Proposals - The SEC aims to alleviate disclosure burdens for small companies by adjusting disclosure requirements based on company size and maturity, and changing reporting periods from quarterly to semi-annually, with 2026 as a key rule-making year [3] - The reform includes a dual pillar strategy: the first pillar limits information disclosure to "financially significant" content, while the second introduces differentiated regulatory mechanisms based on company size and maturity [3] - These measures aim to create a more efficient and friendly listing environment, enhancing the attractiveness of the US capital market for innovative companies [3] Group 3: US OTC Market - The strategic value of the US OTC market has been revitalized for many growing small and medium-sized enterprises that do not meet the stringent standards of Nasdaq [4] - The OTC market offers a low-threshold, low-cost, and flexible access point for small businesses to connect with the US capital market, with a multi-tier structure providing tailored options for companies at different development stages [5] - The OTCID base tier requires only unaudited financial statements with no price or profit thresholds, while the OTCQB growth tier requires audited financials but no mandatory profit requirements, allowing companies to gain compliance experience [5] Group 4: Transition Pathways - Companies can use the OTC market to improve governance structures and accumulate compliance experience, laying the groundwork for future transitions to Nasdaq or the New York Stock Exchange [6] - For example, to apply for a transition to the OTCQB tier, companies must meet one of the following criteria: net assets of at least $5 million; or cumulative net profits of at least $750,000 over two years with net assets of at least $4 million; or a market value of at least $50 million with net assets of at least $4 million [7] - With the deepening of Sino-US regulatory cooperation, the pathways for Chinese companies to go public in the US will become more diversified, allowing companies to choose suitable capital market paths based on their circumstances rather than blindly pursuing high-threshold mainboard listings [7]

Core Viewpoint - The new financial thresholds and stricter substantive reviews imposed by Nasdaq and NYSE are expected to make 2026 a pivotal year for Chinese companies seeking to list in the U.S. The OTC market is emerging as a more flexible alternative for these companies to navigate the challenges of going public abroad [1]. Nasdaq Regulations - Nasdaq has implemented discretionary powers allowing it to reject listings even if companies meet all written requirements if there are risks of securities manipulation [2]. - The minimum public float market capitalization requirement under the net income standard has been raised from $5 million to $15 million [2]. - A new delisting rule states that stocks priced below $0.10 for ten consecutive days will be immediately suspended and initiated for delisting without a grace period [2]. - Special requirements for Chinese companies may include a minimum fundraising of $25 million through IPO or reverse mergers, potentially prohibiting direct listings [2]. NYSE Regulations - NYSE maintains its existing standards while the NYSE American market awaits approval for its new standards [3]. Financial Standards - The fundraising and market capitalization thresholds have been raised to $15 million [4]. Stock Price Standards - The minimum stock price standard has been unified to $4 per share, and the calculation of public shares has been revised to exclude restricted stocks [5]. Market Dynamics - In 2025, only 1 out of 93 Chinese companies listed on U.S. main boards met the new regulations through direct IPO, with nearly 70% of small enterprises raising less than $1 million, contrasting sharply with the $25 million threshold for main boards [5]. - The OTC market, with over 12,000 listed companies and annual trading volumes in the hundreds of billions, is being recognized as a viable capital market ecosystem rather than a secondary option [5]. Advantages of OTC Market - The OTC market offers excellent cost-effectiveness with a listing cycle of only 3-6 months and no mandatory underwriters, significantly reducing compliance uncertainty [5]. - It accommodates various stages of enterprise development, with market makers providing broad coverage and supporting ADR listings to meet diverse financing needs [6]. - The transition to main boards is facilitated, with an average of 52 companies per year moving from OTC to main boards between 2018 and 2022, and a recent case of a Chinese company transitioning in just 6-8 weeks [8]. - The flexible equity structure allows founders to maintain a high level of control [9]. Strategic Considerations for Chinese Companies - Startups should initially consider the OTC ID/Pink Sheets market, while growth-stage tech companies should target OTCQB, and mature companies should aim for OTCQX [10]. - Companies are advised to standardize financial statements according to U.S. GAAP/IFRS and enhance information disclosure to meet dual regulatory requirements [10]. - OTC can serve as a "compliance training ground" to prepare for transitioning to main boards by meeting net asset, shareholder, and market capitalization requirements [10]. - The evolving U.S. market landscape is complemented by improved regulatory processes from the China Securities Regulatory Commission and optimized foreign exchange policies, facilitating the repatriation of funds raised abroad [10].

Core Insights - The China Securities Regulatory Commission (CSRC) has signaled a deeper and higher level of opening for the Chinese capital market, enhancing the regulatory framework for overseas listings, which presents strategic opportunities for domestic companies to plan their overseas expansion [1][3] Group 1: Regulatory Environment - The CSRC's commitment to improving the standardization and transparency of the overseas listing process will help companies reduce uncertainty and compliance costs, making the path to listing more stable [3] - The emphasis on promoting high-quality development alongside risk prevention and strong regulation indicates that support will be directed towards companies with solid fundamentals and sustainable growth capabilities [3] - The directive to enhance institutional inclusiveness reflects the regulatory focus on accommodating various types of companies, especially those with unique technologies or high growth potential that may not meet traditional financial standards [3][4] Group 2: OTC Market Advantages - The OTC market in the U.S. offers lower entry barriers and controllable costs, focusing on operational compliance and information disclosure rather than strict profit or asset requirements, which is beneficial for innovative companies [5][6] - Listing on the OTC market allows companies to establish governance and financial reporting systems that meet international standards, facilitating a smoother transition to major exchanges like NASDAQ or NYSE in the future [6] - The OTC market provides flexible trading mechanisms and regulatory frameworks that support shareholder transactions and incentivize talent acquisition [7][8] Group 3: Strategic Positioning - Utilizing the U.S. OTC market as a first step in a global capital strategy is a rational choice, aligning with domestic regulatory encouragement for compliant overseas expansion while allowing companies to engage with international capital markets in a cost-effective manner [8]